"Designing Growth Strategies is in our DNA"

Migraine Drugs Market Size, Share & Industry Analysis, By Drug Class (Preventative Treatment, Acute Treatment), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And Regional Forecast 2021-2028

Region : Global | Report ID: FBI105116 | Status : Ongoing

 

KEY MARKET INSIGHTS

Migraine is categorized as a neurological medical condition wherein the individual suffers from throbbing and intense headache. Accompanying symptoms may include vomiting, numbness, nausea difficulty speaking, among others. Migraines are also said to be linked genetically and can affect people of all age groups. The throbbing headache can be induced through various external factors such as stress, alcohol, hormonal changes, and food allergies. Migraines are usually self-manageable. However, certain severe cases require medications such as no-steroidal anti-inflammatory drugs, analgesics, antipsychotics, among various other drugs. Increasing adoption of a sedentary lifestyle has presupposed the younger population to migraine pains. This trend is projected to influence market growth in the coming years positively.


The rising prevalence of neurological disorders like migraine among the younger population owed to a higher sedentary lifestyle is estimated to augment the market growth in the coming years. For instance, according to the Migraine Research Foundation, over one billion people worldwide suffer from migraine attacks. The Foundation also states that over 39 million individuals suffer from this neurological condition in the U.S alone.


However, there is limited awareness regarding migraine, and lack of awareness regarding the proper treatment of the disorder in emerging nations is estimated to hamper the market growth.


Key Market Driver -

Rising prevalence of migraine

Key Market Restraint -

Lower diagnosis and awareness regarding migraine


Market Segmentation:


Globally, the migraine drug market can be categorized into product type, distribution channel, and region. Based on drug class, the market can be bifurcated into preventative treatment and acute treatment. Preventative treatment can be further categorized into ergotamine, analgesics, and triptans. Acute treatment includes calcium channel blockers, beta-blockers, anticonvulsants, antidepressants, anti-serotonergic drugs, and others. Based on administration, the market can be divided into oral, injectable, and others. Based on the segmentation of distribution channels, the market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies.


Geographically, the Migraine drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.


Key Players Covered:


Some of the major companies that are present in the migraine drugs market are Amgen, Abbott Laboratories, Allergan, Eli Lilly, Pfizer, Inc., AstraZeneca, Johnson and Johnson Services, Inc., GlaxoSmithKline, and other prominent players


Key Insights:



  • Key Industry Developments – Merger, Acquisitions, and Partnerships

  • Key Product Launches

  • Key Industry Trends

  • Epidemiology of Migraine, Key Regions

  • COVID-19 Impact on Migraine drugs Market


Regional Analysis:


Based on region segmentation, the migraine drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold the major market share in 2020. This is influenced by factors such as the higher preference of key players to launch the product in the region, higher accessibility to prescription and over-the-counter drugs, established healthcare system, among others. North America is anticipated to retain its position throughout the forecast duration. Europe, on the other hand, is projected to hold the second-largest share in the market. This is attributed to factors such as favorable reimbursement policies and non-government support groups that help spread awareness regarding migraine and its available treatment options.


Meanwhile, in countries of Asia Pacific, there is limited knowledge regarding various treatment options for migraines. Lower awareness with respect to the severity of migraine disorder is anticipated to be the factor that limited the expansion of the market in the region. However, increasing disposable income in countries such as India and China could favor market growth in the coming years. Latin America, the Middle East, and Africa are projected to hold significantly lower market share in 2020.


To gain extensive insights into the market, Request for Customization


Segmentation


























 ATTRIBUTE


    DETAILS

By Drug Class




  • Preventative Treatment

    • Ergotamine

    • Analgesics

    • Triptans



  • Acute Treatment

    • Calcium Channel Blockers

    • Beta-Blockers

    • Anti-Convulsants

    • Anti-depressants

    • Anti-serotonergic Drugs

    • Others





By Route of Administration




  • Oral

  • Injectable

  • Others



By Distribution Channel




  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, the Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)



Migraine drugs Market Industry Developments



  • In January 2020, the U.S FDA approved the use of ubrogepant manufactured by Allegran. The drug is indicated to treat acute migraine.

  • In October 2019, the U.S FDA issued 510(k) marketing authorisation for Reyvow manufactured by Eli Lilly and Company. The medication is indicated to treat migraine in adults over 18. years of age


Migraine Drugs Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Ipsos
uniliver
Roche
Fresenius
abbvie

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X